BiotechTube

Breast Neoplasms

14 competing products in clinical development for Breast Neoplasms.

Pipeline by Phase

Phase 12
Phase 1/22
Phase 24
Phase 34
Approved2

All Products (14)

ProductCompanyStageStatusHype
LY4064809 + Placebo + Ribociclib + Palbociclib + Abemaciclib + Anastrozole + Letrozole + Exemestane + FulvestrantEli LillyPhase 3Recruiting
47
Patritumab deruxtecan + Paclitaxel + Nab-paclitaxel + Capecitabine + Liposomal doxorubicin + Trastuzumab deruxtecanDaiichi SankyoPhase 3Recruiting
47
Abemaciclib + Fulvestrant + PlaceboEli LillyPhase 3Active
44
Trastuzumab Deruxtecan + Paclitaxel + Trastuzumab + Pertuzumab + Doxorubicin + cyclophosphamideDaiichi SankyoPhase 3Active
44
Eribulin mesylateEisaiApprovedCompleted
43
Eribulin MesylateEisaiApprovedCompleted
43
Patritumab deruxtecan + Pembrolizumab + Paclitaxel + Carboplatin + Doxorubicin hydrochloride + Epirubicin hydrochloride + Cyclophosphamide + Capecitabine + OlaparibDaiichi SankyoPhase 2Recruiting
42
Patritumab deruxtecan + Trastuzumab + Trastuzumab Biosimilar + Pertuzumab + TucatinibDaiichi SankyoPhase 1/2Recruiting
39
E7070EisaiPhase 2Completed
35
E7389EisaiPhase 2Completed
35
E7090 + Fulvestrant + ExemestaneEisaiPhase 1Active
33
H3B-6545EisaiPhase 1/2Completed
32
H3B-6545 + AntihistamineEisaiPhase 1Completed
29
Eribulin + Doxorubicin + Cyclophosphamide + PegfilgrastimEisaiPhase 2Terminated
27